Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool November 24, 2009 Brian Orelli	52-Week Highs! What's Going On? Even with its recent leap, this stock may belong in your portfolio. Medtronic raised earnings guidance today after a fairly strong quarter, and the stock is hitting new 52-week highs.
The Motley Fool February 17, 2009 Brian Orelli	Investors Heart Medtronic The leaner company is more lovable.
The Motley Fool August 20, 2008 Brian Orelli	Medtronic Muddles Through The medical device maker manages double-digit growth in a tough market.
The Motley Fool February 24, 2010 Brian Orelli	Medtronic Needs to Regrow a Spine Everything else looks fairly good, but the problem I see involves the slight decline in Medtronic's second-largest segment, spinal products.
The Motley Fool November 18, 2004 W.D. Crotty	Medtronic Down, Not Out Internal defibrillator maker's earnings growth rate is slowing down, but its future looks healthy.
The Motley Fool November 18, 2008 Brian Orelli	No Buffer for Medtronic Even though sales grew for the quarter, investors weren't happy.
The Motley Fool May 24, 2007 Ryan Fuhrmann	Chronic Healthiness at Medtronic The med-tech firm isn't growing as fast as it once was, but its fourth-quarter earnings report still managed to beat Wall Street's expectations.
The Motley Fool August 25, 2009 Brian Orelli	Medtronic Takes the Road Less Traveled It looks like this medical devices company is healthy again.
The Motley Fool May 20, 2009 Brian Orelli	Joining to Treat, and Beat, Diabetes Medical-device maker Medtronic and drugmaker Eli Lilly are teaming up to co-promote the companies' diabetes products to doctors and patients.
The Motley Fool February 12, 2004 Jeff Hwang	Rockin' Medtronic The world's premier medical device maker keeps on growing.
The Motley Fool August 22, 2007 Ryan Fuhrmann	Upbeat About Medtronic The future looks bright at medical-device firm Medtronic, and the stock price is reasonable. First quarter sales grew, as overseas revenue improved an impressive 16%.
The Motley Fool May 25, 2010 Brian Orelli	Medtronic Gets Tossed Out With the Bathwater A bad day to report good news.
The Motley Fool February 17, 2005 Stephen D. Simpson	Is Medtronic's Heartbeat Slowing? Will gradually decelerating growth lead to a multiple contraction on the medical device maker's stock?
The Motley Fool August 18, 2005 Stephen D. Simpson	Medtronic Keeps the Beat Strong growth in the ICD and spinal businesses keep Medtronic running. The stock is trading more or less at par to the market with respect to its P/E-to-growth ratio. Investors must decide for themselves whether that's a fair price to pay.
The Motley Fool February 24, 2009 Brian Orelli	Medtronic Hearts Acquisitions Medical device maker Medtronic pays a little over $1 billion for two acquisitions in one day.
The Motley Fool May 26, 2005 Stephen D. Simpson	A Second Opinion on Medtronic Medtronic is a growth stalwart, but does valuation properly account for the challenges?
The Motley Fool May 21, 2008 Brian Orelli	Medtronic's Endeavors Look Good The medical device maker's new drug-eluting stent helps push up revenue.
The Motley Fool November 22, 2011 Brian Orelli	A Little Diversity Goes a Long Way Especially in this economy.
The Motley Fool November 21, 2007 Rich Smith	Medtronic Motors Ahead Shares of the medical equipment maker soared yesterday and continue to buck the downtrend on Wall Street, in the wake of a fiscal Q2 2008 earnings report that exceeded expectations for both sales and profits.
The Motley Fool February 5, 2008 Brian Orelli	Medtronic Endeavors to Compete The U.S. drug-eluting stent market just got a little more crowded, after Medtronic announces that the FDA had approved its Endeavor stent for marketing in the U.S.
The Motley Fool August 31, 2011 Harsh Chauhan	Medtronic Looks Set for Takeoff Medtronic shares jump after flat quarterly growth as it looks toward global expansion.
The Motley Fool February 20, 2008 Brian Orelli	Medtronic Looks Ahead After a rough second half of last year, Medtronic is leaving its problems behind, and optimistically focusing on the future.
The Motley Fool August 18, 2008 Brian Orelli	Foolish Forecast: Taking Medtronic to Heart In advance of earnings analysts expect Medtronic, with another medical device approval, to boost revenues 17%.
The Motley Fool May 26, 2004 Alyce Lomax	Medtronic Takes Heart After the stock drops on data, what does the company have to say?
The Motley Fool July 28, 2010 Brian Orelli	Amplifying the Risk-Reward Ratio Amplify, Medtronic's latest, gets a mixed reaction at FDA advisory panel meeting.
The Motley Fool May 25, 2005 W.D. Crotty	Medtronic's Sneak Preview The medical technology company, a 26-bagger, turns in another strong quarter and fiscal year, then offers quite an outlook.
The Motley Fool October 22, 2011 Harsh Chauhan	This Stock May Be a Surprisingly Good Buy Medtronic's moves could reap dividends in the future.
The Motley Fool May 25, 2011 Brian Orelli	No Red Carpet for Medtronic's New CEO Omar Ishrak, Medtronic's newly-appointed CEO, looks like he has his work cut out for him trying to get the medical-device maker growing again.
BusinessWeek May 29, 2006 Gene G. Marcial	Will Medtronic's Pulse Quicken? Some investors say Medtronic may beat analysts' consensus forecast.
The Motley Fool January 6, 2005 Stephen D. Simpson	Can Medtronic Still Quicken the Pulse? While increased competition looms for the medical device maker, a shareholder update looks to the past.
The Motley Fool November 21, 2006 Ryan Fuhrmann	Shocking Results at Medtronic Favorable earnings boost shares of this medical equipment maker -- but are they too high already?
The Motley Fool March 3, 2011 Bryan Hinmon	Medtronic's Moat Is Strengthening Lessons from an interview with Medtronic CFO Gary Ellis.
The Motley Fool July 7, 2008 Brian Orelli	And Then There Were 4 The number of drug-eluting stent players in the U.S. doubles with the addition of Medtronic's Endeavor and Abbott Labs' Xience V.
The Motley Fool December 29, 2011 Harsh Chauhan	Why Medtronic Is On Course for a Happy New Year Right moves make Medtronic a good investment now.
The Motley Fool August 18, 2011 Todd Wenning	What Does Medtronic Do With Its Free Cash? Is it a good steward of shareholder capital?
The Motley Fool January 18, 2011 Russ Krull	Keep It or Sweep It: Johnson & Johnson? Should the company be held or sold?
The Motley Fool May 29, 2008 Brian Orelli	Medtronic Sticks It to Boston Scientific Medtronic wins the medical-device patent duel with Boston Scientific.
The Motley Fool November 15, 2007 Rich Smith	Foolish Forecast: Mulling Medtronic In advance of earnings reports, analysts expect sales from the medical-equipment maker to remain flat and profit to fall slightly.
The Motley Fool October 16, 2007 Billy Fisher	A Heartbreaker at Medtronic The medical device maker halts distribution of certain defibrillator wires. Shares of Medtronic are now very close to the stock's 52-week low.
The Motley Fool August 6, 2011 Arundhati Parmar	Medtronic Jobs: Firm Will Double Chinese Workforce in 4 Years The company puts its focus on emerging markets.
The Motley Fool March 29, 2011 Brian Orelli	Medtronic's Exciting New Toys The device maker received multiple approvals in less than a week.
The Motley Fool December 9, 2011 Harsh Chauhan	Medtronic Regains Its Footing Medtronic comes up with a strong quarter.
The Motley Fool August 24, 2010 Brian Orelli	Disaster in Medical-Device Land Industry bellwether Medtronic is forecasting a nasty storm.
The Motley Fool May 24, 2006 Stephen D. Simpson	Measuring Up Medtronic Everyone loves the med-tech firm. That makes it a dangerous investment.
The Motley Fool December 8, 2004 Dave Marino-Nachison	J&J Guided to Guidant? Medical device investors felt their hearts skip as executives told The New York Times the two companies may be set to merge.
The Motley Fool August 24, 2011 Brian Orelli	Growth, but Not Great Growth Medtronic's growth comes with lower margins.
The Motley Fool July 6, 2007 Billy Fisher	Medtronic: For the Broken-Hearted Promising clinical trial could bring a new Medtronic stent to market. Investors, take note.
The Motley Fool May 19, 2009 Brian Orelli	Medtronic Gets Whacked, Seeks Recovery Device Medtronic gets hammered on lackluster guidance.
The Motley Fool August 24, 2011 Arundhati Parmar	Growth Is the Deity Medtronic CEO Omar Ishrak Will Worship CEO Omar Ishrak repeatedly said that a singular focus on growth would be his top priority to transform the company.
The Motley Fool August 24, 2011 Andrew Tonner	Does Abbott Laboratories Look Like a Winning Investment? A quick check of their numbers shows us that Abbott Labs looks reasonably attractive.